Empire (TSE:EMP.A – Get Free Report) had its target price boosted by research analysts at National Bankshares from C$40.00 to C$41.00 in a report issued on Friday, BayStreet.CA reports. The brokerage presently has a “sector perform” rating on the stock. National Bankshares’ price objective indicates a potential upside of 19.53% from the company’s previous close.
A number of other analysts have also recently commented on EMP.A. Royal Bank of Canada dropped their price target on Empire from C$42.00 to C$41.00 and set a “sector perform” rating on the stock in a research report on Friday. Desjardins dropped their price target on Empire from C$40.00 to C$39.00 and set a “buy” rating on the stock in a research report on Wednesday, March 6th. TD Securities lowered their price objective on Empire from C$37.00 to C$36.00 and set a “hold” rating on the stock in a research report on Friday, March 15th. CIBC lowered their price objective on Empire from C$42.00 to C$40.00 in a research report on Friday, March 1st. Finally, BMO Capital Markets lowered their price objective on Empire from C$37.00 to C$35.00 in a research report on Friday, March 15th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of C$38.29.
View Our Latest Stock Analysis on Empire
Empire Stock Up 0.6 %
About Empire
Empire Company Limited, together with its subsidiaries, engages in the food retail and related real estate businesses in Canada. It operates through two segments, Food Retailing, and Investments and Other Operations. The company owns, affiliates, and franchises approximately 1,500 retail stores under various retail banners, including Sobeys, Safeway, IGA, Foodland, FreshCo, Thrifty Foods, and Lawtons Drugs; and approximately 350 retail fuel locations.
Featured Stories
- Five stocks we like better than Empire
- Ride Out The Recession With These Dividend KingsĀ
- Sarepta Therapeutics Stock Soars on FDA Approval
- How to buy stock: A step-by-step guide for beginnersĀ
- CarMax: A Market Melt-Up Waiting to Happen for this Stock
- What is a Death Cross in Stocks?
- 3 Solar Stocks to Watch that are Building the Green Energy Future
Receive News & Ratings for Empire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Empire and related companies with MarketBeat.com's FREE daily email newsletter.